Cargando…
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guide...
Autor principal: | Herford, A.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343095/ https://www.ncbi.nlm.nih.gov/pubmed/28236566 http://dx.doi.org/10.1016/j.cjtee.2016.05.004 |
Ejemplares similares
-
Current Status of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Maxillofacial Surgery: Should It Be Continued?
por: On, Sung-Woon, et al.
Publicado: (2023) -
Safety and Efficacy of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) in Craniofacial Surgery
por: Ramly, Elie P., et al.
Publicado: (2019) -
Efficient delivery of recombinant human bone morphogenetic protein (rhBMP-2) with dextran sulfate-chitosan microspheres
por: Xia, Yuan-Jun, et al.
Publicado: (2018) -
Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly
por: Hoffmann, Martin F, et al.
Publicado: (2013) -
Current Trends in Recombinant Human Bone Morphogenetic Protein 2 (rhBMP2) Usage for Spinal Fusion Surgery
por: Patel, Harshadkumar A., et al.
Publicado: (2023)